Epidermal Langerhans Cells

Handbook of Dendritic Cells

Volumn 1, Issue , 2008, Pages 73-100

  Romani, Nikolaus ^a   Tripp, Christoph H ^b   Ratzinger, Gudrun ^b   Heufler, Christine ^b   Koch, Franz ^b   Saeland, Sem ^b   Stoitzner, Patrizia ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b NONE

Author keywords

Epidermis; Langerhans cells; Morphology; Nonlymphoid organs; Ontogeny

Indexed keywords

EID: 84889793975     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527619696.ch5     Document Type: Chapter

References (179)

1. Valladeau, J., Ravel, O., Dezutter-Dambuyant, C., Moore, K., Kleijmeer, M., Liu, Y., Duvert-Frances, V., Vincent, C., Schmitt, D., Davoust, J., Caux, C., Lebecque, S., Saeland, S., Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 2000. 12: 71-81.
2. Valladeau, J., Clair-Moninot, V., Dezutter-Dambuyant, C., Pin, J.J., Kissenpfennig, A., Mattéi, M.G., Ait-Yahia, S., Bates, E.E.M., Malissen, B., Koch, F., Fossiez, F., Romani, N., Lebecque, S., Saeland, S., Identification of mouse Langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J. Immunol. 2002. 168: 782-792.
3. Birbeck, M.S., Breathnach, A.S., Everall, J.D., An electron microscopic study of basal melanocytes and high level clear cells (Langerhans cell) in vitiligo. J. Invest. Dermatol. 1961. 37: 51-64.
4. Wolff, K., The fine structure of the Langerhans cell granule. J. Cell. Biol. 1967. 35: 468-473.
5. Schuler, G., Steinman, R.M., Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 1985. 161: 526-546.
6. Romani, N., Holzmann, S., Tripp, C.H., Koch, F., Stoitzner, P., Langerhans cells - dendritic cells of the epidermis. APMIS 2003. 111: 725-740.
7. Wolff, K., The Langerhans cell. Curr. Probl. Dermatol. 1972. 4: 79-145.
8. Silberberg-Sinakin, I., Gigli, I., Baer, R.L., Thorbecke, G.J., Langerhans cells: role in contact hypersensitivity and relationship to lymphoid dendritic cells and to macrophages. Immunol. Rev. 1980. 53: 203-232.
9. Rowden, G., The Langerhans cell. CRC Crit. Rev. Immunol. 1981. 3: 95-180.
10. Wolff, K., Stingl, G., The Langerhans Cell. J. Invest. Dermatol. 1983. 80: 17s-21s.
11. Schuler, G. (Ed.) Epidermal Langerhans Cells. CRC Press Inc., Boca Raton, Florida 1991.
12. Moll, H. (Ed.) The immune functions of epidermal Langerhans cells. R.G.Landes Company / Springer-Verlag, Austin, New York, Berlin 1995.
13. Maurer, D., Stingl, G., Langerhans Cells. In Lotze, M.T., Thomson, A.W. (Eds.) Dendritic cells: Biology and clinical applications. Academic Press, San Diego, London 2001, pp 35-50.
14. Wilson, N.S., Villadangos, J.A., Lymphoid organ dendritic cells: beyond the Langerhans cells paradigm. Immunol. Cell Biol. 2004. 82: 91-98.
15. Langerhans, P., Über die Nerven der menschlichen Haut. Virchows Arch. [A] 1868. 44: 325-337.
16. Coppes-Zantinga, A., Egeler, R.M., The Langerhans cell histiocytosis X files revealed. Br. J. Haematol. 2002. 116: 3-9.
17. Wolff, K., Winkelmann, R.K., Ultrastructural localization of nucleoside triphosphatase in Langerhans cells. J. Invest. Dermatol. 1967. 48: 50-54.
18. Stingl, G., Wolff-Schreiner, E.C., Pichler, W.J., Gschnait, F., Knapp, W., Epidermal Langerhans cells bear Fc and C3 receptors. Nature 1977. 268: 245-246.
19. Rowden, G., Lewis, M.G., Sullivan, A.K., Ia antigen expression on human epidermal Langerhans cells. Nature 1977. 268: 247-248.
20. Klareskog, L., Malmnas-Tjernlund, U., Forsum, U., Peterson, P.A., Epidermal Langerhans cells express Ia antigens. Nature 1977. 268: 248-250.
21. Katz, S.I., Tamaki, K., Sachs, D.H., Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 1979. 282: 324-326.
22. Frelinger, J.G., Hood, L., Hill, S., Frelinger, J.A., Mouse epidermal Ia molecules have a bone marrow origin. Nature 1979. 282: 321-323.
23. Romani, N., Witmer-Pack, M., Crowley, M., Koide, S., Schuler, G., Inaba, K., Steinman, R.M., Langerhans cells as immature dendritic cells. In Schuler, G. (Ed.) Epidermal Langerhans cells. CRC Press, Inc., Boca Raton, FL 1991, pp 191-216.
24. Wolff, K., The fascinating story that began in 1868. In Schuler, G. (Ed.) Epidermal Langerhans Cells. CRC Press Inc., Boca Raton, FL 1991, pp 1-21.
25. Hausen, B.M., Die Inseln des Paul Langerhans - eine Biographie in Bildern und Dokumenten. Ueberreuter Wissenschaft, Wien, Berlin 1988.
26. Geissmann, F., Prost, C., Monnet, J.P., Dy, M., Brousse, N., Hermine, O., Transforming growth factor â1 in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 1998. 187: 961-966.
27. Strobl, H., Bello-Fernandez, C., Riedl, E., Pickl, W.F., Majdic, O., Lyman, S.D., Knapp, W., flt3 ligand in cooperation with transforming growth factor- â1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood 1997. 90: 1425-1434.
28. Caux, C., Vanbervliet, B., Massacrier, C., Dezutter-Dambuyant, C., De Saint-Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D., Banchereau, J., CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNFα. J. Exp. Med. 1996. 184: 695-706.
29. Macatonia, S.E., Knight, S.C., Edwards, A.J., Griffiths, S., Fryer, P., Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J. Exp. Med. 1987. 166: 1654-1667.
30. Bennett, C.L., van Rijn, E., Jung, S., Inaba, K., Steinman, R.M., Kapsenberg, M.L., Clausen, B.E., Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell. Biol. 2005. 169: 569-576.
31. Kissenpfennig, A., Henri, S., Dubois, B., Laplace-Builhé, C., Perrin, P., Romani, N., Tripp, C.H., Douillard, P., Leserman, L., Kaiserlian, D., Saeland, S., Davoust, J., Malissen, B., Visualizing and eliminating Langerhans dendritic cells in vivo. Dermal dendritic cells arrive in lymph nodes first and colonize areas distinct from slower migrating Langerhans cells. Immunity 2005. 22: 643-654.
32. Kraal, G., Breel, M., Janse, M., Bruin, G., Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J. Exp. Med. 1986. 163: 981-997.
33. MacPherson, G.G., Properties of lymphborne (veiled) dendritic cells in culture. I. Modulation of phenotype, survival and function: Partial dependence on GMCSF. Immunology 1989. 68: 102-107.
34. Silberberg, I., Baer, R.L., Rosenthal, S.A., Thorbecke, G.J., Berezowsky, V., Dermal and intravascular Langerhans cells at sites of passively induced allergic contact sensitivity. Cell. Immunol. 1975. 18: 435-453.
35. Schuler, G., Romani, N., Stössel, H., Wolff, K., Structural organization and biological properties of Langerhans cells. In Schuler, G. (Ed.) Epidermal Langerhans cells. CRC Press Inc., Boca Raton, FL 1991, pp 87-137.
36. Stoitzner, P., Pfaller, K., Stössel, H., Romani, N., A close-up view of migrating Langerhans cells in the skin. J. Invest. Dermatol. 2002. 118: 117-125.
37. Volc-Platzer, B., Stingl, G., Wolff, K., Hinterberg, W., Schnedl, W., Cytogenetic identification of allogeneic epidermal Langerhans cells in a bonemarrow- graft recipient. N. Engl. J. Med. 1984. 310: 1123-1124.
38. Perreault, C., Pelletier, M., Belanger, R., Boileau, J., Bonny, Y., David, M., Gyger, M., Landry, D., Montplaisir, S., Persistence of host Langerhans cells following allogeneic bone marrow transplantation: possible relationship with acute graft-versus-host disease. Br. J. Haematol. 1985. 60: 253-260.
39. Elbe, A., Tschachler, E., Steiner, G., Binder, A., Wolff, K., Stingl, G., Maturational steps of bone marrowderived dendritic murine epidermal cells: Phenotypic and functional studies on Langerhans cells and Thy-1+ dendritic epidermal cells in the perinatal period. J. Immunol. 1989. 143: 2431-2438.
40. Romani, N., Schuler, G., Fritsch, P.O., The ontogeny of Ia-positive and Thy-1 positive leukocytes of murine epidermis. J. Invest. Dermatol. 1986. 86: 129-133.
41. Tripp, C.H., Chang-Rodriguez, S., Stoitzner, P., Holzmann, S., Stössel, H., Douillard, P., Saeland, S., Koch, F., Elbe-Bürger, A., Romani, N., Ontogeny of Langerin/CD207 expression in the epidermis of mice. J. Invest. Dermatol. 2004. 122: 670-672.
42. Dewar, A.L., Doherty, K.V., Woods, G.M., Lyons, A.B., Muller, H.K., Acquisition of immune function during the development of the Langerhans cell network in neonatal mice. Immunology 2001. 103: 61-69.
43. Simpson, C.C., Woods, G.M., Muller, H.K., Impaired CD40-signalling in Langerhans' cells from murine neonatal draining lymph nodes: implications for neonatally induced cutaneous tolerance. Clin. Exp. Immunol. 2003. 132: 201-208.
44. Foster, C.A., Holbrook, K.A., Ontogeny of Langerhans cells in human embryonic and fetal skin: Cell densities and phenotypic expression relative to epidermal growth. Am. J. Anat. 1989. 184: 157-164.
45. Chang-Rodriguez, S., Ecker, R., Stingl, G., Elbe-Bürger, A., Autocrine IL-10 partially prevents differentiation of neonatal dendritic epidermal leukocytes into Langerhans cells. J. Leukoc. Biol. 2004. 76: 657-666.
46. Chang-Rodriguez, S., Hoetzenecker, W., Schwärzler, C., Biedermann, T., Saeland, S., Elbe-Bürger, A., Fetal and neonatal murine dendritic epidermal leukocytes are Langerhans cell precursors. J. Leukoc. Biol. 2005. 77: 352-360.
47. Cook, D.N., Prosser, D.M., Förster, R., Zhang, J., Kuklin, N.A., Abbondanzo, S.J., Niu, X.D., Chen, S.C., Manfra, D.J., Wiekowski, M.T., Sullivan, L.M., Smith, S.R., Greenberg, H.B., Narula, S.K., Lipp, M., Lira, S.A., CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 2000. 12: 495-503.
48. Dieu-Nosjean, M.C., Massacrier, C., Homey, B., Vanbervliet, B., Pin, J.J., Vicari, A., Lebecque, S., Dezutter-Dambuyant, C., Schmitt, D., Zlotnik, A., Caux, C., Macrophage inflammatory protein 3α is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J. Exp. Med. 2000. 192: 705-717.
49. Charbonnier, A.S., Kohrgruber, N., Kriehuber, E., Stingl, G., Rot, A., Maurer, D., Macrophage inflammatory protein 3α is involved in the constitutive trafficking of epidermal Langerhans cells. J. Exp. Med. 1999. 190: 1755-1767.
50. Schmuth, M., Neyer, S., Rainer, C., Grassegger, A., Fritsch, P., Romani, N., Heufler, C., Expression of the C-C chemokine MIP-3alpha/CCL20 in human epidermis with impaired permeability barrier function. Exp. Dermatol. 2002. 11: 135-142.
51. Borkowski, T.A., Letterio, J.J., Farr, A.G., Udey, M.C., A role for endogenous transforming growth factor â1 in Langerhans cell biology: The skin of transforming growth factor â1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 1996. 184: 2417-2422.
52. Borkowski, T.A., Letterio, J.J., Mackall, C.L., Saitoh, A., Wang, X.J., Roop, D.R., Gress, R.E., Udey, M.C., A role for TGFâ1 in Langerhans cell biology - Further characterization of the epidermal Langerhans cell defect in TGFâ1 null mice. J. Clin. Invest. 1997. 100: 575-581.
53. Hacker, C., Kirsch, R.D., Ju, X.S., Hieronymus, T., Gust, T.C., Kuhl, C., Jorgas, T., Kurz, S.M., Rose-John, S., Yokota, Y., Zenke, M., Transcriptional profiling identifies Id2 function in dendritic cell development. Nat. Immunol. 2003. 4: 380-386.
54. Stoitzner, P., Stössel, H., Wankell, M., Hofer, S., Heufler, C., Werner, S., Romani, N., Activin A is involved in the immigration of Langerhans cell precursors into the epidermis. Eur. J. Cell Biol. 2005. 84: 733-741.
55. Krueger, G.G., Emam, M., Biology of Langerhans cells: analysis by experiments to deplete Langerhans cells from human skin. J. Invest. Dermatol. 1984. 82: 613-617.
56. Merad, M., Manz, M.G., Karsunky, H., Wagers, A., Peters, W., Charo, I., Weissman, I.L., Cyster, J.G., Engleman, E.G., Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 2002. 3: 1135-1141.
57. Kanitakis, J., Petruzzo, P., Dubernard, J.M., Turnover of epidermal Langerhans' cells. N. Engl. J. Med. 2004. 351: 2661-2662.
58. Miyauchi, S., Hashimoto, K., Mitotic activities of normal epidermal Langerhans cells. J. Invest. Dermatol. 1989. 92: 120-121.
59. Konrad, K., Hönigsmann, H., Elektronenmikroskopischer Nachweis einer mitotischen Langerhanszelle in normaler menschlicher Epidermis / Electron microscopic demonstration of a mitotic Langerhans cell in the normal human epidermis. Arch. Dermatol. Res. 1973. 246: 70-76.
60. Kamath, A.T., Henri, S., Battye, F., Tough, D.F., Shortman, K., Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 2002. 100: 1734-1741.
61. Ghaznawie, M., Papadimitriou, J.M., Heenan, P.J., The steady-state turnover of murine epidermal Langerhans cells. Br. J. Dermatol. 1999. 141: 57-61.
62. Czernielewski, J., Vaigot, P., Prunieras, M., Epidermal Langerhans cells - a cycling cell population. J. Invest. Dermatol. 1985. 84: 424-426.
63. Hoetzenecker, W., Meingassner, J.G., Ecker, R., Stingl, G., Stütz, A., Elbe-Bürger, A., Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J. Invest. Dermatol. 2004. 122: 673-684.
64. Larregina, A.T., Morelli, A.E., Spencer, L.A., Logar, A.J., Watkins, S.C., Thomson, A.W., Falo, L.D., Jr., Dermalresident CD14+ cells differentiate into Langerhans cells. Nat. Immunol. 2001. 2: 1151-1158.
65. Holzmann, S., Tripp, C.H., Schmuth, M., Janke, K., Koch, F., Saeland, S., Stoitzner, P., Romani, N., A model system using tape stripping for characterization of Langerhans cell-precursors in vivo. J. Invest. Dermatol. 2004. 122: 1165-1174.
66. Breathnach, S.M., Origin, cell lineage, ontogeny, tissue distribution and kinetics of Langerhans cells. In Schuler, G. (Ed.) Epidermal Langerhans Cells. CRC Press Inc., Boca Raton, FL 1991, pp 23-47.
67. Breathnach, A.S., Electron micrographs from a collection. Clin. Exp. Dermatol. 1977. 2: 1.
68. Stoitzner, P., Holzmann, S., McLellan, A.D., Ivarsson, L., Stössel, H., Kapp, M., Kämmerer, U., Douillard, P., Kämpgen, E., Koch, F., Saeland, S., Romani, N., Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J. Invest. Dermatol. 2003. 120: 266-274.
69. Aberer, W., Romani, N., Elbe, A., Stingl, G., Effects of physicochemical agents on murine epidermal Langerhans cells and Thy-1-positive dendritic epidermal cells. J. Immunol. 1986. 136: 1210-1216.
70. Ito, T., Inaba, M., Inaba, K., Toki, J., Sogo, S., Iguchi, T., Adachi, Y., Yamaguchi, K., Amakawa, R., Valladeau, J., Saeland, S., Fukuhara, S., Ikehara, S., A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J. Immunol. 1999. 163: 1409-1419.
71. Gothelf, Y., Hanau, D., Tsur, H., Sharon, N., Sahar, E., Cazenave, J.-P., Gazit, E., T6 positive cells in the peripheral blood of burn patients: Are they Langerhans cells precursors? J. Invest. Dermatol. 1988. 90: 142-148.
72. Merad, M., Hoffmann, P., Ranheim, E., Slaymaker, S., Manz, M.G., Lira, S.A., Charo, I., Cook, D.N., Weissman, I.L., Strober, S., Engleman, E.G., Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 2004. 10: 510-517.
73. Homey, B., Dieu-Nosjean, M.C., Wiesenborn, A., Massacrier, C., Pin, J.J., Oldham, E., Catron, D., Buchanan, M.E., Muller, A., deWaal, M.R., Deng, G., Orozco, R., Ruzicka, T., Lehmann, P., Lebecque, S., Caux, C., Zlotnik, A., Upregulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol. 2000. 164: 6621-6632.
74. Kaser, A., Ludwiczek, O., Holzmann, S., Moschen, A.R., Weiss, G., Enrich, B., Graziadei, I., Dunzendorfer, S., Wiedermann, C.J., Mürzl, E., Grasl, E., Jasarevic, Z., Romani, N., Offner, F.A., Tilg, H., Increased expression of CCL20 in human inflammatory bowel disease. J. Clin. Immunol. 2004. 24: 74-85.
75. Vanbervliet, A., Homey, B., Durand, I., Massacrier, C., Aït-Yahia, S., de Bouteiller, O., Vicari, A., Caux, C., Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces. Eur. J. Immunol. 2002. 32: 231-242.
76. Kadowaki, N., Antonenko, S., Lau, J.Y.N., Liu, Y.J., Natural interferon α/â-producing cells link innate and adaptive immunity. J. Exp. Med. 2000. 192: 219-225.
77. Diebold, S.S., Montoya, M., Unger, H., Alexopoulou, L., Roy, P., Haswell, L.E., Al Shamkhani, A., Flavell, R., Borrow, P., Reis e Sousa, C., Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003. 424: 324-328.
78. Manz, M.G., Traver, D., Miyamoto, T., Weissman, I.L., Akashi, K., Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood 2001. 97: 3333-3341.
79. Anjuère, F., Del Hoyo, G.M., Martín, P., Ardavín, C., Langerhans cells develop from a lymphoid-committed precursor. Blood 2000. 96: 1633-1637.
80. Schiavoni, G., Mattei, F., Borghi, P., Sestili, P., Venditti, M., Morse, H.C., III, Belardelli, F., Gabriele, L., ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood 2004. 103: 2221-2228.
81. Ichikawa, E., Hida, S., Omatsu, Y., Shimoyama, S., Takahara, K., Miyagawa, S., Inaba, K., Taki, S., Defective development of splenic and epidermal CD4+ dendritic cells in mice deficient for IFN regulatory factor-2. Proc. Natl. Acad. Sci. USA 2004. 101: 3909-3914.
82. Burkly, L., Hession, C., Ogata, L., Reilly, C., Marconi, L.A., Olson, D., Tizard, R., Cate, R., Lo, D., Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 1995. 373: 531-536.
83. Georgopoulos, K., Bigby, M., Wang, J.H., Molnar, A., Wu, P., Winandy, S., Sharpe, A., The Ikaros gene is required for the development of all lymphoid lineages. Cell 2005. 79: 143-156.
84. Radtke, F., Ferrero, I., Wilson, A., Lees, R., Aguet, M., MacDonald, H.R., Notch1 deficiency dissociates the intrathymic development of dendritic cells and T cells. J. Exp. Med. 2000. 191: 1085-1093.
85. Iwama, A., Osawa, M., Hirasawa, R., Uchiyama, N., Kaneko, S., Onodera, M., Shibuya, K., Shibuya, A., Vinson, C., Tenen, D.G., Nakauchi, H., Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors in Langerhans cell commitment. J. Exp. Med. 2002. 195: 547-558.
86. Borkowski, T.A., Van Dyke, B.J., Schwarzenberger, K., McFarland, V.W., Farr, A.G., Udey, M.C., Expression of Ecadherin by murine dendritic cells: Ecadherin as a dendritic cell differentiation antigen characteristic of epidermal Langerhans cells and related cells. Eur. J. Immunol. 1994. 24: 2767-2774.
87. Borkowski, T.A., Nelson, A.J., Farr, A.G., Udey, M.C., Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (Ep-CAM), by murine dendritic cells. Eur. J. Immunol. 1996. 26: 110-114.
88. Zhao, X.Y., Deak, E., Soderberg, K., Linehan, M., Spezzano, D., Zhu, J., Knipe, D.M., Iwasaki, A., Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective th1 responses to herpes simplex virus-2. J. Exp. Med. 2003. 197: 153-162.
89. Ruedl, C., Koebel, P., Bachmann, M., Hess, M., Karjalainen, K., Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J. Immunol. 2000. 165: 4910-4916.
90. Henri, S., Vremec, D., Kamath, A., Waithman, J., Williams, S., Benoist, C., Burnham, K., Saeland, S., Handman, E., Shortman, K., The dendritic cell populations of mouse lymph nodes. J. Immunol. 2001. 167: 741-748.
91. Valladeau, J., Duvert-Frances, V., Pin, J.J., Dezutter-Dambuyant, C., Vincent, C., Massacrier, C., Vincent, J., Yoneda, K., Banchereau, J., Caux, C., Davoust, J., Saeland, S., The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur. J. Immunol. 1999. 29: 2695-2704.
92. Kissenpfennig, A., Aït-Yahia, S., Clair-Moninot, V., Stössel, H., Badell, E., Bordat, Y., Pooley, J.L., Lang, T., Prina, E., Coste, I., Gresser, O., Renno, T., Winter, N., Milon, G., Shortman, K., Romani, N., Lebecque, S., Malissen, B., Saeland, S., Douillard, P., Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function. Mol. Cell. Biol. 2005. 25: 88-99.
93. Douillard, P., Stoitzner, P., Tripp, C.H., Clair-Moninot, V., Ait-Yahia, S., McLellan, A., Eggert, A., Romani, N., Saeland, S., Mouse lymphoid tissue contains distinct subsets of Langerin / CD207+ dendritic cells, only one of which represents epidermal-derived Langerhans cells. J. Invest Dermatol. 2005. 125: 983-994.
94. Geissmann, F., Dieu-Nosjean, M.C., Dezutter, C., Valladeau, J., Kayal, S., Leborgne, M., Brousse, N., Saeland, S., Davoust, J., Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J. Exp. Med. 2002. 196: 417-430.
95. Movassagh, M., Spatz, A., Davoust, J., Lebecque, S., Romero, P., Pittet, M., Rimoldi, D., Lienard, D., Gugerli, O., Ferradini, L., Robert, C., Avril, M.F., Zitvogel, L., Angevin, E., Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma. Cancer Res. 2004. 64: 2192-2198.
96. McLellan, A.D., Kapp, M., Eggert, A., Linden, C., Bommhardt, U., Bröcker, E.B., Kämmerer, U., Kämpgen, E., Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression. Blood 2002. 99: 2084-2093.
97. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., Steinman, R.M., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/ macrophage colony-stimulating factor. J. Exp. Med. 1992. 176: 1693-1702.
98. Douillard, P., Ait-Yahia, S., Stoitzner, P., Clair-Moninot, V., Romani, N., Saeland, S., Expression of Langerin / CD207 reveals dendritic cell heterogeneity between inbred mouse strains. J. Leukoc. Biol. 2005. in press.
99. Wilson, N.S., El Sukkari, D., Belz, G.T., Smith, C.M., Steptoe, R.J., Heath, W.R., Shortman, K., Villadangos, J.A., Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 2003. 102: 2187-2194.
100. Stoitzner, P., Tripp, C.H., Douillard, P., Saeland, S., Romani, N., Migratory Langerhans cells in mouse lymph nodes in steady state and inflammation. J. Invest. Dermatol. 2005. 125: 166-125.
101. De Saint-Vis, B., Vincent, J., Vandenabeele, S., Vanbervliet, B., Pin, J.J., Aït-Yahia, S., Patel, S., Mattei, M.G., Banchereau, J., Zurawski, S., Davoust, J., Caux, C., Lebecque, S., A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 1998. 9: 325-336.
102. Steinman, R.M., Cohn, Z.A., Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 1973. 137: 1142-1162.
103. Inaba, K., Schuler, G., Witmer, M.D., Valinski, J., Atassi, B., Steinman, R.M., Immunologic properties of purified epidermal Langerhans cells.Distinct requirements for stimulation of unprimed and sensitized T lymphocytes. J. Exp. Med. 1986. 164: 605-613.
104. Reise Sousa, C., Stahl, P.D., Austyn, J.M., Phagocytosis of antigens by Langerhans cells in vitro. J. Exp. Med. 1993. 178: 509-519.
105. Romani, N., Koide, S., Crowley, M., Witmer-Pack, M., Livingstone, A.M., Fathman, C.G., Inaba, K., Steinman, R.M., Presentation of exogenous protein antigens by dendritic cells to T cell clones: intact protein is presented best by immature epidermal Langerhans cells. J.Exp.Med. 1989. 169: 1169-1178.
106. Kämpgen, E., Koch, N., Koch, F., Stöger, P., Heufler, C., Schuler, G., Romani, N., Class II major histocompatibility complex molecules of murine dendritic cells: Synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc. Natl. Acad. Sci. USA 1991. 88: 3014-3018.
107. Puré, E., Inaba, K., Crowley, M.T., Tardelli, L., Witmer-Pack, M.D., Ruberti, G., Fathman, G., Steinman, R.M., Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. J. Exp. Med. 1990. 172: 1459-1469.
108. Stössel, H., Koch, F., Kämpgen, E., Stöger, P., Lenz, A., Heufler, C., Romani, N., Schuler, G., Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J. Exp. Med. 1990. 172: 1471-1482.
109. Witmer-Pack, M.D., Olivier, W., Valinsky, J., Schuler, G., Steinman, R.M., Granulocyte/macrophage colonystimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J. Exp. Med. 1987. 166: 1484-1498.
110. Heufler, C., Koch, F., Schuler, G., Granulocyte-macrophage colonystimulating factor and interleukin-1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med. 1988. 167: 700-705.
111. Koch, F., Heufler, C., Kämpgen, E., Schneeweiss, D., Böck, G., Schuler, G., Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture but in contrast to granulocyte/macrophage colony-stimulating factor without inducing their functional maturation. J. Exp. Med. 1990. 171: 159-171.
112. Romani, N., Lenz, A., Glassel, H., Stössel, H., Stanzl, U., Majdic, O., Fritsch, P., Schuler, G., Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J. Invest. Dermatol. 1989. 93: 600-609.
113. Teunissen, M.B.M., Wormmeester, J., Krieg, S.R., Peters, P.J., Vogels, I.M.C., Kapsenberg, M.L., Bos, J.D., Human epidermal Langerhans cells undergo profound morphological and phenotypical changes during in vitro culture. J. Invest. Dermatol. 1990. 94: 166-173.
114. Pierre, P., Turley, S.J., Gatti, E., Hull, M., Meltzer, J., Mirza, A., Inaba, K., Steinman, R.M., Mellman, I., Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997. 388: 787-792.
115. Randolph, G.J., Sanchez-Schmitz, G., Angeli, V., Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances. Springer Semin. Immunopathol. 2005. 26: 273-287.
116. Romani, N., Ratzinger, G., Pfaller, K., Salvenmoser, W., Stössel, H., Koch, F., Stoitzner, P., Migration of dendritic cells into lymphatics - The Langerhans cell example: Routes, regulation, and relevance. Int. Rev. Cytol. 2001. 207: 237-270.
117. Romani, N., Holzmann, S., Tripp, C.H., Sixt, M., Stoitzner, P., Trafficking of dendritic cells. In Hamann, A., Engelhardt, B. (Eds.) Leukocyte Trafficking. Wiley-VCH Publishers, New York, Weinheim 2005, pp 184-215.
118. Randolph, G.J., Angeli, V., Swartz, M.A., Dendritic cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 2005. 5: 617-628.
119. Cumberbatch, M., Dearman, R.J., Griffiths, C.E.M., Kimber, I., Epidermal Langerhans cell migration and sensitisation to chemical allergens. APMIS 2003. 111: 797-804.
120. Vermaelen, K.Y., Carro-Muino, I., Lambrecht, B.N., Pauwels, R.A., Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 2001. 193: 51-60.
121. Shortman, K., Liu, Y.J., Mouse and human dendritic cell subtypes. Nature Rev. Immunol. 2002. 2: 151-161.
122. Wilson, N.S., Villadangos, J.A., Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. Adv. Immunol. 2005. 86: 241-305.
123. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Durand, I., Cella, M., Lanzavecchia, A., Banchereau, J., CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor α .2. Functional analysis. Blood 1997. 90: 1458-1470.
124. De Saint-Vis, B., Fugier-Vivier, I., Massacrier, C., Gaillard, C., Vanbervliet, B., Aït-Yahia, S., Banchereau, J., Liu, Y.J., Lebecque, S., Caux, C., The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J. Immunol. 1998. 160: 1666-1676.
125. Ebner, S., Ehammer, Z., Holzmann, S., Schwingshackl, P., Forstner, M., Stoitzner, P., Huemer, G.M., Fritsch, P., Romani, N., Expression of C-type lectin receptors by subsets of dendritic cells in human skin. Int. Immunol. 2004. 16: 877-887.
126. Geijtenbeek, T.B., Van Kooyk, Y., Pathogens target DC-SIGN to influence their fate DC-SIGN functions as a pathogen receptor with broad specificity. APMIS 2003. 111: 698-714.
127. Turville, S., Wilkinson, J., Cameron, P., Dable, J., Cunningham, A.L., The role of dendritic cell C-type lectin receptors in HIV pathogenesis. J. Leukoc. Biol. 2003. 74: 710-718.
128. Takahara, K., Yashima, Y., Omatsu, Y., Yoshida, H., Kimura, Y., Kang, Y.S., Steinman, R.M., Park, C.G., Inaba, K., Functional comparison of the mouse DC-SIGN, SIGNR1, SIGNR3 and Langerin, C-type lectins. Int. Immunol. 2004. 16: 819-829.
129. Hunger, R.E., Sieling, P.A., Ochoa, M.T., Sugaya, M., Burdick, A.E., Rea, T.H., Brennan, P.J., Belisle, J.T., Blauvelt, A., Porcelli, S.A., Modlin, R.L., Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J. Clin. Invest. 2004. 113: 701-708.
130. Stingl, G., Katz, S.I., Clements, L., Green, I., Shevach, E.M., Immunologic functions of Ia-bearing epidermal Langerhans cells. J. Immunol. 1978. 121: 2005-2013.
131. Pehamberger, H., Stingl, L.A., Pogantsch, S., Steiner, G., Wolff, K., Stingl, G., Epidermal cell-induced generation of cytotoxic T-lymphocyte responses against alloantigens or TNPmodified syngeneic cells: requirement for Ia-positive Langerhans cells. J. Invest. Dermatol. 1983. 81: 208-211.
132. Braathen, L.R., Thorsby, E., Studies on human epidermal langerhans cells. IV. HLA-D restriction of langerhans celldependent antigen activation of T lymphocytes. Scand. J. Immunol. 1982. 15: 55-61.
133. McKinney, E.C., Streilein, J.W., On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo. J. Immunol. 1989. 143: 1560-1564.
134. Stoitzner, P., Tripp, C. H., Romani, N. Murine Langerhans cells cross-present protein antigens from the skin to CD8+ T cells. Proceedings of the Dendritic Cell Symposium Brugge, October 2004. Abstract
135. Wu, S.J.L., Grouard-Vogel, G., Sun, W., Mascola, J.R., Brachtel, E., Putvatana, R., Louder, M.K., Filgueira, L., Marovich, M.A., Wong, H.K., Blauvelt, A., Murphy, G.S., Robb, M.L., Innes, B.L., Birx, D.L., Hayes, C.G., Frankel, S.S., Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 2000. 6: 816-820.
136. Labuda, M., Austyn, J.M., Zuffova, E., Kozuch, O., Fuchsberger, N., Lysy, J., Nuttall, P.A., Importance of localized skin infection in tick-borne encephalitis virus transmission. Virology 1996. 219: 357-366.
137. Reece, J.C., Handley, A.J., Anstee, E.J., Morrison, W.A., Crowe, S.M., Cameron, P.U., HIV-1 selection by epidermal dendritic cells during transmission across human skin. J. Exp. Med. 1998. 187: 1623-1631.
138. Moll, H., Fuchs, H., Blank, C., Röllinghoff, M., Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen- specific T cells. Eur. J. Immunol. 1993. 23: 1595-1601.
139. Silberberg-Sinakin, I., Thorbecke, G.J., Contact hypersensitivity and Langerhans cells. J. Invest. Dermatol. 1980. 75: 61-67.
140. Weinlich, G., Heine, M., Stössel, H., Zanella, M., Stoitzner, P., Ortner, U., Smolle, J., Koch, F., Sepp, N.T., Schuler, G., Romani, N., Entry into afferent lymphatics and maturation in situ of migrating cutaneous dendritic cells. J. Invest. Dermatol. 1998. 110: 441-448.
141. Toews, G.B., Bergstresser, P.R., Streilein, J.W., Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J. Immunol. 1980. 124: 445-453.
142. Sullivan, S., Bergstresser, P.R., Tigelaar, R., Streilein, J.W., Induction and regulation of contact hypersensitivity by resident, bone marrow-derived, dendritic epidermal cells: Langerhans cells and Thy-1+ epidermal cells. J. Immunol. 1986. 137: 2460-2467.
143. Serbina, N.V., Pamer, E.G., Immunology. Giving credit where credit is due. Science 2005. 301: 1856-1857.
144. Allan, R.S., Smith, C.M., Belz, G.T., Van Lint, A.L., Wakim, L.M., Heath, W.R., Carbone, F.R., Epidermal viral immunity induced by CD8α+ dendritic cells but not by Langerhans cells. Science 2003. 301: 1925-1928.
145. Negoescu, A., Guillermet, C., Lorimier, P., Brambilla, E., Labat-Moleur, F., Importance of DNA fragmentation in apoptosis with regard to TUNEL specificity. Biomed. Pharmacother. 1998. 52: 252-258.
146. Ritter, U., Meissner, A., Scheidig, C., Körner, H., CD8α- and Langerinnegative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur. J. Immunol. 2004. 34: 1542-1550.
147. Sugaya, M., Nakamura, K., Watanabe, T., Asahina, A., Yasaka, N., Koyama, Y., Kusubata, M., Ushiki, Y., Kimura, K., Morooka, A., Irie, S., Yokoyama, T., Inoue, K., Itohara, S., Tamaki, K., Expression of cellular prion-related protein by murine Langerhans cells and keratinocytes. J. Dermatol. Sci. 2002. 28: 126-134.
148. Mohan, J., Bruce, M.E., Mabbott, N.A., Neuroinvasion by scrapie following inoculation via the skin is independent of migratory Langerhans cells. J. Virol. 2005. 79: 1888-1897.
149. Streilein, J.W., Antigen-presenting cells in the induction of contact hypersensitivity in mice: Evidence that Langerhans cells are sufficient but not required. J. Invest. Dermatol. 1989. 93: 443-448.
150. Bacci, S., Alard, P., Dai, R.P., Nakamura, T., Streilein, J.W., High and low doses of haptens dictate whether dermal or epidermal antigen-presenting cells promote contact hypersensitivity. Eur. J. Immunol. 1997. 27: 442-448.
151. Steinman, R.M., Hawiger, D., Nussenzweig, M.C., Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003. 21: 685-711.
152. Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M.C., Steinman, R.M., Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 2002. 196: 1627-1638.
153. Bonifaz, L.C., Bonnyay, D.P., Charalambous, A., Darguste, D.I., Fujii, S.I., Soares, H., Brimnes, M.K., Moltedo, B., Moran, T.M., Steinman, R.M., In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 2004. 199: 815-824.
154. Mahnke, K., Guo, M., Lee, S., Sepulveda, H., Swain, S.L., Nussenzweig, M., Steinman, R.M., The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 2000. 151: 673-683.
155. Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J.V., Steinman, R.M., Nussenzweig, M.C., Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 2001. 194: 769-779.
156. Hemmi, H., Yoshino, M., Yamazaki, H., Naito, M., Iyoda, T., Omatsu, Y., Shimoyama, S., Letterio, J.J., Nakabayashi, T., Tagaya, H., Yamane, T., Ogawa, M., Nishikawa, S., Ryoke, K., Inaba, K., Hayashi, S., Kunisada, T., Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-â1-dependent cells. Int. Immunol. 2001. 13: 695-704.
157. Ohl, L., Mohaupt, M., Czeloth, N., Hintzen, G., Kiafard, Z., Zwirner, J., Blankenstein, T., Henning, G., Förster, R., CCR7 Governs Skin Dendritic Cell Migration under Inflammatory and Steady-State Conditions. Immunity 2004. 21: 279-288.
158. Mayerova, D., Parke, E.A., Bursch, L.S., Odumade, O.A., Hogquist, K.A., Langerhans cells activate naïve selfantigen specific CD8 T cells in the steady state. Immunity 2004. 21: 391-400.
159. Azukizawa, H., Kosaka, H., Sano, S., Heath, W.R., Takahashi, I., Gao, X.H., Sumikawa, Y., Okabe, M., Yoshikawa, K., Itami, S., Induction of T-cell-mediated skin disease specific for antigen transgenically expressed in keratinocytes. Eur. J. Immunol. 2003. 33: 1879-1888.
160. Shibaki, A., Sato, A., Vogel, J.C., Miyagawa, F., Katz, S.I., Induction of GVHD-like skin disease by passively transferred T cell receptor transgenic CD8+ T cells into keratin-14-ovalbumin transgenic mice. J. Invest. Dermatol. 2004. 123: 109-115.
161. Banchereau, J., Palucka, A.K., Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 2005. 5: 296-306.
162. Schuler, G., Schuler-Thurner, B., Steinman, R.M., The use of dendritic cells in cancer immunotherapy. Curr. Opin. Immunol. 2003. 15: 138-147.
163. Cerundolo, V., Hermans, I.F., Salio, M., Dendritic cells: a journey from laboratory to clinic. Nat. Immunol. 2004. 5: 7-10.
164. Berger, T.G., Feuerstein, B., Strasser, E., Hirsch, U., Schreiner, D., Schuler, G., Schuler-Thurner, B., Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories(TM). J. Immunol. Methods 2002. 268: 131-140.
165. Caux, C., Dezutter-Dambuyant, C., Schmitt, D., Banchereau, J., GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 1992. 360: 258-261.
166. Paczesny, S., Banchereau, J., Wittkowski, K.M., Saracino, G., Fay, J., Palucka, A.K., Expansion of Melanoma-specific Cytolytic CD8+ T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34+ Progenitorderived Dendritic Cells. J. Exp. Med. 2004. 199: 1503-1511.
167. Palucka, A.K., Dhodapkar, M.V., Paczesny, S., Burkeholder, S., Wittkowski, K.M., Steinman, R.M., Fay, J., Banchereau, J., Single injection of CD34+ progenitor-derived dendritic cell vaccine can lead to induction of T-cell immunity in patients with stage IV melanoma. J. Immunother. 2003. 26: 432-439.
168. Banchereau, J., Palucka, A.K., Dhodapkar, M., Burkeholder, S., Taquet, N., Rolland, A., Taquet, S., Coquery, S., Wittkowski, K.M., Bhardwaj, N., Pineiro, L., Steinman, R.M., Fay, J., Immune and clinical responses in patients with metastatic melanoma to CD34+ progenitorderived dendritic cell vaccine. Cancer Res. 2001. 61: 6451-6458.
169. Ratzinger, G., Baggers, J., de Cos, M.A., Yuan, J., Dao, T., Reagan, J.L., Münz, C., Heller, G., Young, J.W., Mature human Langerhans cells derived from CD34+ hemopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermalinterstitial or monocyte-derived dendritic cells. J. Immunol. 2004. 173: 2780-2791.
170. Yuan, J., Latouche, J.B., Reagan, J.L., Heller, G., Riviere, I., Sadelain, M., Young, J.W., Langerhans cells derived from genetically modified human CD34+ hemopoietic progenitors are more potent than peptide-pulsed Langerhans cells for inducing antigen-specific CD8+ cytolytic T lymphocyte responses. J. Immunol. 2005. 174: 758-766.
171. Klimuk, S.K., Najar, H.M., Semple, S.C., Aslanian, S., Dutz, J.P., Epicutaneous application of CpG oligodeoxynucleotides with peptide or protein antigen promotes the generation of CTL. J. Invest. Dermatol. 2004. 122: 1042-1049.
172. Partidos, C.D., Beignon, A.S., Mawas, F., Belliard, G., Briand, J.P., Muller, S., Immunity under the skin: potential application for topical delivery of vaccines. Vaccine 2003. 21: 776-780.
173. Bynoe, M.S., Evans, J.T., Viret, C., Janeway, C.A., Jr., Epicutaneous immunization with autoantigenic peptides induces T suppressor cells that prevent experimental allergic encephalomyelitis. Immunity 2003. 19: 317-328.
174. Rechtsteiner, G., Warger, T., Osterloh, P., Schild, H., Radsack, M.P., Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod. J. Immunol. 2005. 174: 2476-2480.
175. Seo, N., Tokura, Y., Nishijima, T., Hashizume, H., Furukawa, F., Takigawa, M., Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. Proc. Natl. Acad. Sci. USA 2000. 97: 371-376.
176. Belyakov, I.M., Hammond, S.A., Ahlers, J.D., Glenn, G.M., Berzofsky, J.A., Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J. Clin. Invest. 2004. 113: 998-1007.
177. Strunk, D., Egger, C., Leitner, G., Hanau, D., Stingl, G., A skin homing molecule defines the Langerhans cell progenitor in human peripheral blood. J. Exp. Med. 1997. 185: 1131-1136.
178. Jung, S., Unutmaz, D., Wong, P., Sano, G.I., los Santos, K., Sparwasser, T., Wu, S.J., Vuthoori, S., Ko, K., Zavala, F., Pamer, E.G., Littman, D.R., Lang, R.A., In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 2002. 17: 211-220.
179. Kaplan, D.H., Jenison, M.C., Saeland, S., Shlomchik, W.D., Shlomchik, M.J., Epidermal Langerhans cell deficient mice develop enhanced contact hypersensitivity. Immunity 2005. 23: in press